Connect with us

#CORONAVIRUS

Anti-viral Drug Remdesivir Accelerates Recovery Of COVID-19 Patients – New Study

Published

on

Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America’s top infectious diseases expert said the study showed the medication has “clear-cut” benefits.

Complete results from the research, which was carried out by US government agency the National Institute of Allergy and Infectious Diseases (NIAID), were published by leading medical periodical the New England Journal of Medicine.

The United States authorized the emergency use of remdesivir in hospitals on May 1, followed by Japan, while Europe is considering following suit.

The study found that remdesivir, injected intravenously daily for 10 days, accelerated the recovery of hospitalized COVID-19 patients compared to a placebo in clinical tests on just over a thousand patients across 10 countries.

On April 29, NIAID director Anthony Fauci, who has become the US government’s trusted face on the coronavirus pandemic, said preliminary evidence indicated remdesivir had a “clear-cut, significant and positive effect in diminishing the time to recovery.”

The National Institutes of Health, of which the NIAID is a part, said Friday in a statement online that investigators found “remdesivir was most beneficial for hospitalized patients with severe disease who required supplemental oxygen.”

Advertisement
Article Banner

But the authors of the trial wrote that the drug did not prevent all deaths.

“Given high mortality despite the use of remdesivir, it is clear that treatment with an anti-viral drug alone is not likely to be sufficient,” they said.

About 7.1 percent of patients given remdesivir in the trial group died within 14 days — compared with 11.9 percent in the placebo group.

However, the result is just below the statistical reliability threshold, meaning it could be down to chance rather than the capability of the drug.

AFP

Advertisement
Article Banner
Continue Reading
Advertisement
Click to comment
FEATURES1 hour ago

Sowore Blasts Adeleke Over Tinubu Visit Amid Osun Violence

FEATURED3 hours ago

Tinubu Receives Re-Elected Adeleke at Aso Rock, First Meeting Since Osun Victory

FEATURED8 hours ago

Oil Resumption: MOSOP Assures Ogoni People of a Good Deal, Announces Minor Cabinet Changes

Defense and Security10 hours ago

Tinubu Assigns Famadewa to Lead Service Chiefs, Ribadu for 5-Year National Security Threat Assessment, Defence Strategy Development

FEATURES11 hours ago

2027: Extend Your Love For Me To President Tinubu, Oborevwori Tells Religious Leaders

FEATURES11 hours ago

Oborevwori Sets to Inaugurate Perm Secretaries Quarters Today

FEATURES12 hours ago

Omo-Agege Warns Delta Gov: You’ll be Held Responsible If My Family or I Come Under Attack as Campaigns Begin

Defense and Security21 hours ago

Nigerian Navy Boosts Maritime Defense as CNS Inaugurates State-of-the-Art SSV-KALI 3 Vessel Built in Delta

secure number one position
FEATURES23 hours ago

Osogbo Shooting — Police Confirm 60-Year-Old Man Dead, Vows to Arrest Suspects

FEATURED1 day ago

Tinubu Appoints Enitan as New Head of Civil Service as Walson-Jack Bows Out

FEATURES1 day ago

Onaiyakan Breaks Silence Over Presidency’s Diatribe, Declares ‘I Am Unshaken, Fear No One’

Defense and Security1 day ago

BREAKING: Governor Adeleke ‘Escapes Death’ as Gunmen Attack Convoy in Osogbo

Defense and Security1 day ago

UNICEF Demands Urgent Release of 78 Abducted Borno Schoolchildren

secure number one position
FEATURES1 day ago

FCT Police Arrest 40 Over Traffic Robbery, Kidnapping, Armed Robbery

FEATURES1 day ago

‘No Ban On Nigerians’ — South Africa Dismisses Visa Stoppage Rumours

Advertisement
Advertisement

z

   


Article Banner